source
- FDA approves Sanofi's teplizumab for children with stage 3 type 1 diabetesThe FDA announced approval of teplizumab, a Sanofi developed therapy, for children aged 8 and older who have stage 3 type 1 diabetes. The decision came through the agency’s accelerated review path…
- WHO chief warns of worsening Ebola outbreak in DRC and Uganda after on-site visitThe World Health Organization's director‑general said he is "really worried" after returning from a second trip to the Ebola‑affected regions of the Democratic Republic of the Congo and Uganda. He…